Delee Corp

<p>Delee is a medical device company that has created a state-of-the-art technology, the CytoCatch™? System, which is capable of efficiently isolating and analyzing circulating tumor cells from blood. This technology enables the performance of a CTC blood-based assay that has the potential of being used for early cancer detection and monitoring the applied treatments’ effectiveness, allowing the optimization of each patient’s therapy throughout the course of the disease.</p>